drug

mizagliflozin

4 stories · latest Sep 22, 2026

Timeline

Vogenx appoints Ken Toombs to board of directors

Sep 22PeopleVogenx, Inc.

Vogenx registers Phase 2b trial of mizagliflozin for post-bariatric hypoglycemia

Aug 12Trial updatemizagliflozin Vogenx, Inc.

Vogenx prices $81.25 million IPO ahead of Nasdaq listing under VOGX

Aug 12FinancingVogenx, Inc.

Vogenx files for IPO, plans Nasdaq listing under "VOGX"

Jul 15Financingmizagliflozin Vogenx, Inc.